바이오서저리 시장 규모, 점유율, 성장 분석 : 제품별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Biosurgery Market size was valued at USD 16.63 Billion in 2024 and is poised to grow from USD 17.78 Billion in 2025 to USD 30.32 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global biosurgery market is poised for substantial growth due to increased investments from governmental and private sectors in the medical device arena, coupled with rising R&D expenditures. Key drivers include the surging prevalence of chronic diseases, heightened demand for elective surgeries, and substantial funding for healthcare infrastructure. The aging population and the rising incidence of severe traumatic injuries also contribute significantly to market expansion. The growing number of medical firms manufacturing innovative biosurgery products further supports this growth trajectory. Increased surgical procedures and sports-related injuries are further propelling the demand for biosurgery solutions, while ongoing R&D efforts within the medical device and pharmaceutical industries create promising opportunities for market evolution. Overall, these factors collectively enhance the biosurgery landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biosurgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biosurgery Market Segments Analysis

Global Biosurgery Market is segmented by Product, Application, End User, end user and region. Based on Product, the market is segmented into Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants & Adhesives, Adhesion Barriers, Staple-Line and Reinforcement Agents. Based on Application, the market is segmented into Orthopedic Surgery, General Surgery,Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Urological Surgery, Thoracic Surgery, and Other Applications. Based on End User, the market is segmented into Hospitals, Clinics, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Biosurgery Market

The global biosurgery market is experiencing significant growth driven by the rising prevalence of chronic diseases such as diabetes, obesity, and heart conditions. These health issues frequently necessitate surgical interventions, leading to an increased demand for innovative biosurgical solutions that promote healing and enhance the likelihood of successful surgical outcomes. As healthcare providers seek advanced products that can support patient recovery and optimize surgical techniques, the market for biosurgery items continues to expand. This demand is fueled by ongoing advancements in technology and an emphasis on improving patient care through effective surgical interventions.

Restraints in the Biosurgery Market

One of the significant challenges facing the biosurgery market is the limited awareness and training surrounding the latest techniques and products. Many healthcare professionals may not fully recognize the benefits and applications of advanced biosurgical methods, resulting in their underutilization. This educational gap can impede the adoption of innovative approaches, ultimately stalling progress in the enhancement of surgical practices. Without sufficient knowledge and training, the potential of these advanced biosurgical options may remain unexploited, thereby curtailing market growth and the overall evolution of surgical techniques that could benefit patients.

Market Trends of the Biosurgery Market

A significant market trend in the global biosurgery market is the increasing adoption of minimally invasive surgical procedures. This shift is driven by advancements in surgical techniques and technologies, which enhance patient outcomes and reduce recovery times. As healthcare providers prioritize patient safety and comfort, biosurgery products-such as biopolymers, hemostatic agents, and sealants-are gaining traction for their efficacy in wound healing and tissue repair. Additionally, the growing prevalence of chronic diseases and the need for advanced surgical interventions are propelling research and innovation in biosurgery, with a focus on integrating biological materials to improve surgical efficacy.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Analysis
• Supply Chain Analysis

Biosurgery Market by Product

• Market Overview
• Bone-Graft Substitutes
  • Demineralized Bone Matrix
  • Synthetic Bone Grafts
  • Bone Morphogenetic Proteins
  • Other Bone-Graft Substitutes
• Soft-Tissue Attachments
  • Synthetic Meshes
  • Biological Meshes
  • Allografts
  • Xenografts
• Hemostatic Agents
  • Thrombin-Based Hemostatic Agents
  • Oxidized Regenerated Cellulose-Based Hemostatic Agents
  • Combination Hemostatic Agents
• Surgical Sealants & Adhesives
  • Natural/Biological Sealants & Adhesives
  • By Type
  • Fibrin-Based Sealants & Adhesives
  • Collagen-Based Sealants & Adhesives
  • Gelatin-Based Sealants & Adhesives
  • Albumin-Based Sealants
  • Other Natural/Biological Sealants & Adhesives
  • By Origin
  • Animal-Based Sealants & Adhesives
  • Human Blood-Based Sealants & Adhesives
  • Synthetic And Semi-Synthetic Sealants & Adhesives
  • PEG Hydrogel-Based Sealants & Adhesives
  • Cyanoacrylate-Based Sealants & Adhesives
  • Urethane-Based Sealants & Adhesives
  • Other Synthetic and Semi-Synthetic Sealants & Adhesives
• Adhesion Barriers
  • Synthetic Adhesion Barriers
  • Hyaluronic Acid-Based Adhesion Barriers
  • Regenerated Cellulose-Based Adhesion Barriers
  • PEG-Based Adhesion Barriers
  • Other Synthetic Adhesion Barriers
  • Natural Adhesion Barriers
  • Collagen And Protein Adhesion Barriers
  • Fibrin-Based Adhesion Barriers
• Staple-Line Reinforcement Agents

Biosurgery Market by Application

• Market Overview
• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Reconstructive Surgery
• Gynecological Surgery
• Urological Surgery
• Thoracic Surgery
• Other Applications

Biosurgery Market by End User

• Market Overview
• Hospitals
• Clinics
• Other End Users

Biosurgery Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2025

Key Company Profiles

• Baxter International Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson & Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra Lifesciences Holdings Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Commonwealth Serum Laboratories Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemostasis LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuros Biosciences AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix Medical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tissue Regenix Group Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Betatech Medical (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samyang Holdings Corporation (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aroa Biosurgery Ltd. (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meyer-Haake Gmbh (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biom Up (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocer Entwicklungs-Gmbh (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hannox International Corp. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments